Results 61 to 70 of about 42,317 (192)

Protective Effects Induced by a Novel Food Supplement Based on Epilobium angustifolium, Ptychopetalum olacoides, Ginkgo biloba, and Equisetum arvense Extracts and Citrulline in the Lower Urinary Tract: Preclinical and Clinical Evidence

Phytotherapy Research, EarlyView.
ABSTRACT Oxyfil is a dietary supplement including plant extracts from Epilobium angustifolium, Ptychopetalum olacoides (Muira puama), Ginkgo biloba, and Equisetum arvense and citrulline. The aim of the study was to investigate the protective effects on prostatic muscles of the Oxyfil formulation in an in vitro experimental model consisting of isolated ...
Annalisa Chiavaroli, Alessandra Acquaviva, Simonetta Cristina Di Simone, Stefano Salvatore, Silvia Messina, Carolina Morgante, Chiara Lupi, Silvia Villa, Gokhan Zengin, Giustino Orlando, Luigi Menghini, Claudio Ferrante, Luigi Schips, Luca Cindolo, Michele Marchioni   +14 more
wiley   +1 more source

Liquid biopsy in genitourinary oncology: Current clinical applications and future prospects across prostate, bladder, and renal cancers

UroPrecision, EarlyView.
Abstract Liquid biopsy has emerged as a transformative approach in oncology, providing minimally invasive access to tumor‐derived biomarkers with applications across diagnosis, prognosis, therapeutic guidance, and disease monitoring. This literature review synthesizes evidence from 125 studies evaluating circulating tumor DNA, circulating tumor cells ...
Kirolos Eskandar
wiley   +1 more source

Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel, Aureliane Pierret, Edouard G. Mills, Alexander N. Comninos, Waljit S. Dhillo, Ali Abbara   +5 more
wiley   +1 more source

Mapping the lineage of prostate tissue ablation medical device predicates for focal therapy of prostate cancer approved via the FDA 510(k) clearance pathway

Surgical Practice, EarlyView.
Abstract Objective Medical devices are reviewed by the US Food and Drug Administration (FDA) for safety and effectiveness. Class II devices can receive 510(k) clearance if they are “substantially equivalent” to an existing predicate device. This process can be repeated iteratively, leading to a lineage of predicates for newly cleared devices.
Yiting Lin, Amir Khan, Arvin George, Mohummad Minhaj Siddiqui   +3 more
wiley   +1 more source

The Impact of VDR-FokI Polymorphism in Iraqi Patients with Prostate Cancer and Prostate Benign Hyperplasia

مجلة بغداد للعلوم
The polymorphism in the vitamin D receptor gene FokI position is used to evaluate the polymorphism impact on the levels of vitamin D, testosterone and prolactin hormones in the sera of patients with prostate cancer and benign prostatic hyperplasia vs ...
Asmaa Amer Almuktar, Luma Hassan Alwan Al Obaidy, Amal Mohammed Ali   +2 more
doaj   +1 more source

Association between Hyperglycemia and Prostate Volume in Patients with Benign Prostate Enlargement : A Hospital Case-Control Study

Journal of Biomedicine and Translational Research, 2017
Introduction: Prostate is a male organ which might enlarge mostly, either benign or malignant. Hyperglycemia is one of the factor that increase the risk of  benign prostate hyperplasia.
Eriawan Agung Nugroho, Rickky Kurniawan
doaj   +1 more source

Transition Zone Prostate Cancer: Quantitative Synthetic MR Imaging and Diffusion‐Weighted Imaging in Tumour Detection

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Background Differentiating transition zone (TZ) prostate cancer (PCa) from benign prostatic hyperplasia (BPH) on multiparametric MRI is challenging. The comparative performance of synthetic MRI (Sy‐MRI) and apparent diffusion coefficient (ADC) for this task is unclear.
Yu Zhang, Feng Li, Lei Song, Yanlong Jia, Zhihao Li, Shijun Jia   +5 more
wiley   +1 more source

Evaluation of the Role of Losartan in the Prevention of Benign Prostate Hyperplasia in Rats

Pakistan Armed Forces Medical Journal
Objective: To evaluate the preventive role of Losartan in testosterone-induced Benign Prostate Hyperplasia in an adult rat model. Study Design: Laboratory-based experimental study.
Arooj Shahid, Akbar Waheed, Shabana Ali, Kulsoom Farhat, Sikandar Mehmood, Mehwish Amin   +5 more
doaj   +1 more source

Molecular detection of Human Papillomavirus genotype-16&-18 in tissues from patients with prostate cancer and benign prostatic hyperplasia

مجلة كلية الطب, 2011
Background: High oncogenic-risk genotypes of human Papillomavirus (HPV) infect a wide range of human cells, including prostate tissue that give rise to benign prostatic hyperplasia and prostatic adenocarcinomas. Objectives: This study aimed to detect DNA
Taghreed F. AL-Mahbobi, Saad H. Mohammed Ali, Mohammed A. AL- Kurtas   +2 more
doaj   +1 more source

Interventional Radiology Society of Australasia Quality Care Guidelines for Prostate Artery Embolisation for Men With Symptomatic Benign Prostatic Hyperplasia in Australia and New Zealand

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Objective This guideline defines recommendations for the provision of quality care for prostate artery embolisation (PAE) treatment for symptomatic benign prostatic hyperplasia (BPH). It has been developed using the AGREE‐II framework and aligns with current evidence, sourced from Randomised Controlled Trials, meta‐analyses and expert ...
William E. L. Ormiston, Glen Schlaphoff, Andrew Owen, Brendan Buckley, Dinesh Ranatunga, Christopher Rogan, Nicholas I. Brown   +6 more
wiley   +1 more source